Literature DB >> 27936979

Thrombocytopenia and infections.

Massimo Franchini1, Dino Veneri2, Giuseppe Lippi3.   

Abstract

INTRODUCTION: Acquired thrombocytopenia recognizes a myriad of causes. Among these, infectious diseases play a relevant role since a low platelet count is commonplace along with other abnormal laboratory data. Areas covered: This narrative review, after a brief presentation of the possible pathogenic mechanisms, is focused on the most prevalent infections associated with thrombocytopenia, namely those attributable to hepatitis C virus (HCV), human immunodeficiency virus (HIV) and Helicobacter pylori. Expert commentary: An underlying HCV or HIV infection should always be suspected in patients at risk who present with isolated thrombocytopenia. The eradication of Helicobacter pylori is advisable in infected patients with secondary immune thrombocytopenia, because this will increase the platelet count in a substantial number of cases, thus avoiding more aggressive and prolonged treatments.

Entities:  

Keywords:  HCV; HIV; Helicobacter pylori; Infections; thrombocytopenia

Mesh:

Year:  2016        PMID: 27936979     DOI: 10.1080/17474086.2017.1271319

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  14 in total

1.  Plasma cell-free DNA predicts pediatric cerebral malaria severity.

Authors:  Iset Medina Vera; Anne Kessler; Li-Min Ting; Visopo Harawa; Thomas Keller; Dylan Allen; Madi Njie; McKenze Moss; Monica Soko; Ajisa Ahmadu; Innocent Kadwala; Stephen Ray; Tonney S Nyirenda; Wilson L Mandala; Terrie E Taylor; Stephen J Rogerson; Karl B Seydel; Kami Kim
Journal:  JCI Insight       Date:  2020-06-18

Review 2.  COVID-19-induced immune thrombocytopenic purpura; Immunopathogenesis and clinical implications.

Authors:  Mohammad Bahadoram; Ali Saeedi-Boroujeni; Mohammad-Reza Mahmoudian-Sani; Helai Hussaini; Shakiba Hassanzadeh
Journal:  Infez Med       Date:  2022-03-01

3.  Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Authors:  Hashem B El-Serag; John Y Kao; Fasiha Kanwal; Mark Gilger; Frank LoVecchio; Steven F Moss; Sheila E Crowe; Adam Elfant; Thomas Haas; Ronald J Hapke; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-17       Impact factor: 11.382

Review 4.  Platelets in HIV: A Guardian of Host Defence or Transient Reservoir of the Virus?

Authors:  Etheresia Pretorius
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 5.  Hyperemesis gravidarum induced refeeding syndrome causes blood cell destruction: a case report and literature review.

Authors:  Xiyu Pan; Ran Chu; Jinyu Meng; Qiannan Wang; Yue Zhang; Kun Song; Xingsheng Yang; Beihua Kong
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-09       Impact factor: 3.007

6.  Predictive significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte for cytomegalovirus infection in infants less than 3 months: A retrospective study.

Authors:  Canyang Zhan; Weiyan Wang; Lihua Chen
Journal:  J Clin Lab Anal       Date:  2021-11-22       Impact factor: 3.124

7.  Immune thrombocytopenia in a patient with COVID-19.

Authors:  Emilie Deruelle; Omar Ben Hadj Salem; Sonnthida Sep Hieng; Claire Pichereau; Hervé Outin; Matthieu Jamme
Journal:  Int J Hematol       Date:  2020-07-16       Impact factor: 2.490

Review 8.  Crosstalk Between Platelets and Microbial Pathogens.

Authors:  Conglei Li; June Li; Heyu Ni
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

9.  Delayed treatment-free response after romiplostim discontinuation in pediatric chronic immune thrombocytopenia.

Authors:  Hyun Ji Lim; Young Tae Lim; Jeong Ok Hah; Jae Min Lee
Journal:  Yeungnam Univ J Med       Date:  2020-08-07

10.  Epidemiology and Viral Etiology of Pediatric Immune Thrombocytopenia through Korean Public Health Data Analysis.

Authors:  Jae Hee Lim; Yu Kyeong Kim; So Hyeon Min; Sang Won Kim; Young Hwan Lee; Jae Min Lee
Journal:  J Clin Med       Date:  2021-03-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.